Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema

Jennifer E. Thorne, Elizabeth A. Sugar, Janet T. Holbrook, Alyce E. Burke, Michael M. Altaweel, Albert T. Vitale, Nisha R. Acharya, John H. Kempen, Douglas A. Jabs

Open source

DOI
10.1016/j.ophtha.2018.08.021
Published
2019-02
Container
Ophthalmology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ophtha.2018.08.021,
  title = {Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema},
  author = {Jennifer E. Thorne and Elizabeth A. Sugar and Janet T. Holbrook and Alyce E. Burke and Michael M. Altaweel and Albert T. Vitale and Nisha R. Acharya and John H. Kempen and Douglas A. Jabs},
  year = {2019},
  journal = {Ophthalmology},
  doi = {10.1016/j.ophtha.2018.08.021},
  url = {https://doi.org/10.1016/j.ophtha.2018.08.021}
}

RIS

TY  - JOUR
TI  - Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema
AU  - Jennifer E. Thorne
AU  - Elizabeth A. Sugar
AU  - Janet T. Holbrook
AU  - Alyce E. Burke
AU  - Michael M. Altaweel
AU  - Albert T. Vitale
AU  - Nisha R. Acharya
AU  - John H. Kempen
AU  - Douglas A. Jabs
PY  - 2019
JO  - Ophthalmology
DO  - 10.1016/j.ophtha.2018.08.021
UR  - https://doi.org/10.1016/j.ophtha.2018.08.021
ER  - 

APA

Thorne, J. E., Sugar, E. A., Holbrook, J. T., Burke, A. E., Altaweel, M. M., Vitale, A. T., Acharya, N. R., Kempen, J. H., & Jabs, D. A. (2019). Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema. Ophthalmology. https://doi.org/10.1016/j.ophtha.2018.08.021

Source records